U. Costabel (Essen, Germany), M. Thomeer (Leuven, Belgium)
Combined emphysema & interstitial pulmonary disease. A new disease entity?
S. Shaker, A. Dirksen, L. Laursen, K. Bach, P. Tonnesen (Hellerup, Denmark)
|  |
Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis
P. Rottoli, E. Bargagli, F. A. Cimmino, M. Galeazzi, R. Marcolongo (Siena, Italy)
| |
Interstitial lung disease in Sjogren's syndrome
S. A. Wright, R. P. Convery, N. Liggett (Craigavon, United Kingdom)
| |
Serum KL-6 level and DTPA clearance in systemic sclerosis patients
H. Sato, N. Goh, R. Janssen, J. C. Grutters, S. Veeraraghavan, P. Pantelidis, A. U. Wells, K. I. Welsh, N. Kohno, R. M. du Bois (London, United Kingdom; Nieuwegein, The Netherlands; Hiroshima, Japan)
| |
Usual interstitial pneumonia(UIP):different evolution in Idiophatic pulmonary fibrosis(IPF) in contrast of UIP secondary to other diseases?
P. Monteiro, M. Fonseca, R. Melo, D. Moniz, A. Bugalho de Almeida (Lisboa, Portugal)
| |
Clinical course of nonspecific interstitial pneumonia: sequential HRCT findings
Y. Inoue, M. Akira, T. Arai, S. Yamamoto, A. Yoshida, K. Inoue, Y. Kashiwa, E. Fujita, S. Yotsumoto, S. Minamoto, K. Suzuki, N. Okada, K. Kimura, M. Sakatani (Sakai/Nagasone, Japan)
| |
IFIGENIA-study: methods, patient characteristics and diagnostic confirmation by independent HRCT and histology committees
M. Demedts, M. Thomeer, J. Verschakelen, F. Laurent, C. D. R. Flower, A. G. Nicholson, E. K. Verbeken, F. Capron, U. Costabel, J. Behr, B. Wallaert, I. Lankhorst, A. Ardia, G. Corvasce, the IFIGENIA Study Group ()
| |
Results and complications of surgical lung biopsy
J. Warzelhan, S. Eric, H. Martin, H. Joachim (Freiburg, Germany)
| |